Glaxosmithkline | Custo De Mercadoria Vendida



Cost Of Sales Alterar Data
AbbVie USD 4.4B 184M 2024-12
Amgen USD 3.11B 198M 2024-12
AstraZeneca USD 2.72B 263M 2024-12
Aurora Cannabis CAD 78.85M 891K 2024-12
Bausch Health Companies USD 696M 23M 2024-09
Bristol-Myers Squibb USD 3.21B 356M 2024-12
Canopy Growth CAD 50.66M 9.51M 2024-12
Corcept Therapeutics USD 2.96M 89K 2024-12
Drreddys Laboratories INR 34.53B 2.14B 2024-12
Eli Lilly USD 2.4B 233M 2024-12
GlaxoSmithKline GBP 2.56B 162M 2024-12
Glaxosmithkline GBP 2.52B 199M 2024-12
Indivior 59M 7M 2024-09
J&J USD 7.11B 151M 2024-12
Merck USD 3.71B 181M 2024-12
Novartis USD 3.32B 90M 2024-12
Pacira USD 39.89M 1.02M 2024-12
Perrigo USD 752.4M 69.3M 2024-12
Pfizer USD 5.65B 781M 2024-12
Prestige Brands USD 129.27M 2.86M 2024-12
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 4.08B 675M 2024-09
Supernus Pharmaceuticals USD 17.2M 385K 2024-12
Takeda JPY 416.87B 22.56B 2024-12
Teva Pharmaceutical Industries USD 2.11B 18M 2024-12
Zoetis USD 707M 8M 2024-12



Glaxosmithkline Custo De Mercadoria Vendida - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.